<!DOCTYPE html>
<html lang="en"><head>
<script src="hipofiz-hastaliklari_files/libs/clipboard/clipboard.min.js"></script>
<script src="hipofiz-hastaliklari_files/libs/quarto-html/tabby.min.js"></script>
<script src="hipofiz-hastaliklari_files/libs/quarto-html/popper.min.js"></script>
<script src="hipofiz-hastaliklari_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="hipofiz-hastaliklari_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="hipofiz-hastaliklari_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="hipofiz-hastaliklari_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="hipofiz-hastaliklari_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <meta name="author" content="Serdar BalcÄ±">
  <title>Title</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="hipofiz-hastaliklari_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="hipofiz-hastaliklari_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="hipofiz-hastaliklari_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="hipofiz-hastaliklari_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="hipofiz-hastaliklari_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="hipofiz-hastaliklari_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="hipofiz-hastaliklari_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAEU0lEQVRYCcVXTWhcVRQ+586kSUMMxkyaElstCto2SIhitS5Ek8xUKV2poatCcVHtUlFQk8mbaaziwpWgglJwVaquitBOfhQXFlqlzSJpFSpIYyXNjBNiTCck7x2/8/LeNDOZxDuEkgOXe++553zfefee+/OYLOXFk3+1LLrRdiO81yNqZ6K9cG0P3MeFaMIQjXssE8Z1JzLO9ls20MBZX7oG8w9GxB0goaPrW5aNMp1yOZIa7Wv6o2ykpLtmAPs/vrG14Z+6d4jpbSKuhdcSyq9wGMPXjonwmESXrriLzFGOdDBLB8Y6MNYBu0dRokSygMA/mrun8MGFN3behm6VVAwg4WR3i6FvYK1T7MHo9BK7ydH+1uurECoouk5MPRyVSBrBHMYwVobG2aOXM07sWrn5qgB60rc6mcwIDJtQrnrEr44kmy+UO9r0u9O5/YbkS9juQckLed3DyW2XV/qWBBB3ptvI8EUY3I9p/67OW+g967TNr3Sotn3IuVlfMLVnsBwH4fsnebJvyGm5GeIUA3jljERmrv49SizPYuq+z7c2H/jlGC+Ghhupn/hcapqmcudB9jwJ/3jvnvu6vu5lVzF1fXyZuZZ7U8nRmVzytvT+H3kilYvH09mLWrQdwFSsFEsxFVs5fK7A0g8gMZjbif4ACpKbjv7gNGaD8bUrlk8x+KRflttr22JEMRUbTUwwDQScyzPgedQHZT0xnx7ujw2jfVfExwYHwOsDTjLdJ2ebmeQIlJ7neo41s/DrsL3kl+W2lWvAga0tR3zueGr6GL78M3ifH0rGXrBC2aAR8uYcIA5gwV8zIE8onoh8u0Fca/ciF7j1uOzEnqcIm59sEXoGc0+z6+H45V1CvAvHcD7THztu669cnp+L0okAeIc6zjbM/24LgGM1gZk7jnRu1aQWoU9sfUOuhrmtaPIO3YY1KLLWZaEO5TKUbMY5zx8W9UJ6elpLwKXbsaZ4EFl7B4bMtDv0iRipKoDQT2sNQI9b1utXFdYisi+wzZ/ri/1m7QfDgEuvgUUEIJPq3DhX/5DWNqIXDOweC2wvIR90Oq3lDpdMIgD2r0dXvGdsEW5H6x6HLRJYU7C69VefO1x8Gde1ZFSJLfWS1jbCnhtOPxmpfv2LXOA2Xk2tvnwKKPFuZ/oRmwBwqRQDcKNeVQkYcOjtWVBuM/JuYw5b6isojIkYxyYAFn5K7ZBF10fea52y8QltAg6jnMqNHFBmGkQ1j+U43HMi2xMar1Nv0zGsf1s8nUsmUtPOOrbFIR8bHFDMB5zL13Gmr/kGlCkUzedTzzmzsaJXhYawnA3UmARpiYj5ooJZiUoxFRtK3X6pgNPv+IZVPcnwbOl6f+aBaO1CNvPW9n9LmCp01nuSaTRF2YxHqZ8DYQT6WsXT+RD6eUztwYLZ8rM+rcPxamv1VQzFUkzFXvkiVrySGQgJNvXHJAxiU3/NwiC03rSf05VBaPtu/Z7/B8Yn/w7eguloAAAAAElFTkSuQmCC');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Title</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar BalcÄ± 
</div>
</div>
</div>

</section>
<section id="davutun-golyatÄ±-Ã¶ldÃ¼rmesi-i.samuel" class="title-slide slide level1 center">
<h1>Davutâun GolyatâÄ± ÃldÃ¼rmesi (I.Samuel)</h1>
<p><strong>1.Sa.17: 4 Filist ordugahÄ±ndan GatlÄ± Golyat adÄ±nda usta bir dÃ¶vÃ¼ÅÃ§Ã¼ortaya Ã§Ä±ktÄ±. </strong> <strong>Boyu </strong> <strong>altÄ± arÅÄ±n bir karÄ±ÅtÄ±*fe*.D Not 17:4 âAltÄ± arÅÄ±n bir karÄ±Åâ: </strong> <strong>YaklaÅÄ±k 2.9 m</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 5 BaÅÄ±na tunÃ§* miÄfer takmÄ±Å, pullu bir zÄ±rh kuÅanmÄ±ÅtÄ±. </strong> <strong>TunÃ§ zÄ±rhÄ±n aÄÄ±rlÄ±ÄÄ±</strong> __ beÅ bin Åekeldi*ff*.D Not 17:5 âBeÅ bin Åekelâ: __ <strong>YaklaÅÄ±k 57.5 kg</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 6 BaldÄ±rlarÄ± zÄ±rhlarla korunmuÅtu. OmuzlarÄ± arasÄ±nda tunÃ§ bir pala asÄ±lÄ±ydÄ±.</strong></p>
<p><strong>1.Sa.17: 7 MÄ±zraÄÄ±nÄ±n sapÄ± dokumacÄ± tezgahÄ±nÄ±n sÄ±rÄ±ÄÄ± gibiydi. </strong> <strong>MÄ±zraÄÄ±ndemir baÅÄ±nÄ±n aÄÄ±rlÄ±ÄÄ±</strong> __ altÄ± yÃ¼z Åekeldi*fg*. GolyatâÄ±n Ã¶nÃ¼sÄ±ra kalkanÄ±nÄ± taÅÄ±yan bir adam yÃ¼rÃ¼yordu.D Not 17:7 âAltÄ± yÃ¼z Åekelâ: __ <strong>YaklaÅÄ±k 6.9 kg</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 8 Golyat durup Ä°srail ordusuna, âNeden savaÅ dÃ¼zeni aldÄ±nÄ±z?â diye haykÄ±rdÄ±, âBen Filistliâyim, sizse Saulâun kÃ¶lelerisiniz. AranÄ±zdan karÅÄ±ma Ã§Ä±kacak birini seÃ§in.</strong></p>
<p><strong>1.Sa.17: 38 Sonra kendi giysilerini Davutâa verdi; baÅÄ±na tunÃ§ miÄfer taktÄ±, ona bir zÄ±rh giydirdi.</strong></p>
<p><strong>1.Sa.17: 39 Davut giysilerinin Ã¼zerine kÄ±lÄ±cÄ±nÄ± kuÅanÄ±p yÃ¼rÃ¼meye Ã§alÄ±ÅtÄ±. ÃÃ¼nkÃ¼ bu giysilere alÄ±ÅÄ±k deÄildi. Saulâa, âBunlarla yÃ¼rÃ¼yemiyorumâ dedi, âÃÃ¼nkÃ¼ alÄ±ÅÄ±k deÄilim.â Sonra giysileri Ã¼zerinden Ã§Ä±kardÄ±.</strong></p>
<p><strong>1.Sa.17: 40 DeÄneÄini alÄ±p dereden beÅ Ã§akÄ±l taÅÄ± seÃ§ti. BunlarÄ± Ã§oban daÄarcÄ±ÄÄ±nÄ±n cebine koyduktan sonra </strong> <strong>sapanÄ±nÄ± alÄ±p Filistli Golyatâa doÄru ilerledi</strong> <strong>.</strong></p>
<p><strong>1.Sa.17: 48 Golyat saldÄ±rmak amacÄ±yla Davutâa doÄru ilerledi. Davut daonunla dÃ¶vÃ¼Åmek Ã¼zere hemen Filist cephesine doÄru koÅtu.</strong></p>
<p><strong>1.Sa.17: 49 </strong> <strong>Elini daÄarcÄ±ÄÄ±na sokup bir taÅ Ã§Ä±kardÄ±, sapanla fÄ±rlattÄ±.TaÅ Filistliânin alnÄ±na Ã§arpÄ±p saplandÄ±. Filistli yÃ¼zÃ¼koyun yere dÃ¼ÅtÃ¼.</strong></p>
<p><strong>1.Sa.17: 50 BÃ¶ylece Davut Filistli GolyatâÄ± sapan ve taÅla yendi.Elinde kÄ±lÄ±Ã§ olmaksÄ±zÄ±n onu yere serdi.</strong></p>
<p><strong>1.Sa.17: 51 Sonra koÅup Ã¼zerine Ã§Ä±ktÄ±. GolyatâÄ±n kÄ±lÄ±cÄ±nÄ± tutupkÄ±nÄ±ndan Ã§ektiÄi gibi onu Ã¶ldÃ¼rdÃ¼ ve baÅÄ±nÄ± kesti.Kahraman GolyatâÄ±n Ã¶ldÃ¼ÄÃ¼nÃ¼ gÃ¶ren Filistliler kaÃ§tÄ±lar.</strong></p>
<p><strong>Pierre Puget âDavid, vainqueur de Goliathâ </strong></p>
<p><em>A History of Acromegaly </em> <strong>Pituitary 1999;2:7â28</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B10.jpg"></p>
<p><strong>Undoubtedly Goliathâs great size was due to </strong> <strong>acromegaly </strong> <strong>secondary to a pituitary macroadenoma. This pituitary adenoma was apparently large enough to induce </strong> <strong>visual field deficits</strong> __ by its pressure on the optic chiasm, which made Goliath __ <strong>unable to follow the young David </strong> <strong>as he circled him. The </strong> <strong>stone entered Goliathâs cranial vault </strong> <strong>through a </strong> <strong>markedly thinned frontal bone</strong> <strong>, which resulted from enlargement of the frontal paranasal sinus, a frequent feature of acromegaly. The stone lodged in Goliathâs enlarged pituitary and caused a </strong> <strong>pituitary hemorrhage</strong> <strong>, resulting in </strong> <strong>transtentorial herniation and death</strong> <strong>.</strong></p>
<p><strong>Radiology. 1990 Jul;176(1):288. </strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B11.jpg"></p>
</section>

<section id="hipofiz-pitÃ¼iter-hastalÄ±klarÄ±" class="title-slide slide level1 center">
<h1>Hipofiz (PitÃ¼iter) HastalÄ±klarÄ±</h1>

</section>

<section id="dr.-serdar-balci" class="title-slide slide level1 center">
<h1>Dr.&nbsp;Serdar BALCI</h1>

</section>

<section id="hipofiz-pitÃ¼iter-bezi" class="title-slide slide level1 center">
<h1>Hipofiz (PitÃ¼iter) bezi</h1>
<ul>
<li><strong>KÃ¼Ã§Ã¼k, fasulye Åeklinde</strong></li>
<li><strong>Sella turcica iÃ§inde beyin tabanÄ±nda yer alÄ±r</strong></li>
<li><strong>Hipotalamus ile iliÅkili</strong>
<ul>
<li><strong>Sap (stalk), aksonlar</strong></li>
<li><strong>VenÃ¶z pleksus</strong></li>
</ul></li>
<li><strong>Anterior lob (Adenohipofiz)</strong></li>
<li><strong>Posterior lob (NÃ¶rohipofiz)</strong></li>
</ul>
</section>

<section id="adenohipofiz" class="title-slide slide level1 center">
<h1>Adenohipofiz</h1>
<ul>
<li><strong>Epitelyal hÃ¼creler</strong></li>
<li><strong>Embriyolojik olarak oral kaviteden geliÅir</strong></li>
<li><strong>Normal histoloji:</strong>
<ul>
<li><strong>SitoplazmalarÄ±nÄ±n rengine gÃ¶re</strong></li>
<li><strong>Bazofilik, eozinofilik, kromofobik hÃ¼crelerden oluÅur</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B12.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B13.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B14.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B15.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B16.jpg"></p>
</section>

<section id="hipofiz-hastalÄ±klarÄ±" class="title-slide slide level1 center">
<h1>Hipofiz hastalÄ±klarÄ±</h1>
<ul>
<li><strong>HiperpitÃ¼itarizm</strong>
<ul>
<li><strong>Trofik hormonlarÄ±n fazla sekresyonu</strong></li>
<li><strong>Anterior bÃ¶lgede hipofiz adenomu</strong></li>
</ul></li>
<li><strong>HipopitÃ¼itarizm</strong>
<ul>
<li><p><strong>Trofik hormonlarÄ±n yokluÄu</strong></p></li>
<li><p><strong>Ä°skemik hasar, cerrahi, radyasyon, diÄer inflamatuar reaksiyonlar</strong></p></li>
<li><p><strong>Nonfonksiyone pitÃ¼ter adenomlar normal yapÄ±larÄ± yÄ±kar</strong></p></li>
<li><p><strong>Lokal kitle etkisi</strong></p></li>
<li><p><strong>Sella geniÅlemesi, kemik erezyonu, sella diafragmasÄ±nÄ±n hasarÄ±</strong></p></li>
<li><p><strong>Optik kiazmadaki Ã§aprazlayan liflere basÄ±</strong></p>
<ul>
<li><strong>lateral (temporal) gÃ¶rme defektleri, bitemporal hemianopsia</strong></li>
</ul></li>
<li><p><strong>Ä°ntrakraniyel basÄ±nÃ§ artÄ±ÅÄ±</strong></p>
<ul>
<li><strong>BaÅaÄrÄ±sÄ±, bulantÄ±, kusma</strong></li>
</ul></li>
<li><p><strong>Beyin tabanÄ±na uzanÄ±m</strong></p>
<ul>
<li><strong>Ä°nvaziv hipofiz adenomu</strong></li>
<li><strong>NÃ¶bet veya obstrÃ¼ktif tip hidrosefalus</strong></li>
<li><strong>Kraniyel sinir felci</strong></li>
</ul></li>
<li><p><strong>Adenom iÃ§ine akut kanama</strong></p>
<ul>
<li><strong>Lezyonun hÄ±zlÄ± geniÅlemesi</strong></li>
<li><strong>PitÃ¼iter apopleksi</strong></li>
<li><strong>HÄ±zlÄ± Ã¶lÃ¼mcÃ¼l</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="hiperpitÃ¼itarizm" class="title-slide slide level1 center">
<h1>HiperpitÃ¼itarizm</h1>
<ul>
<li><strong>En sÄ±k neden anterior lob kaynaklÄ± adenom</strong></li>
<li><strong>Daha az sÄ±klÄ±kla</strong>
<ul>
<li><strong>Hiperplazi</strong></li>
<li><strong>Anterior hipofiz karsinomlarÄ±</strong></li>
<li><strong>EkstrapitÃ¼iter tÃ¼mÃ¶rlerden hormon sekresyonu</strong></li>
<li><strong>Hipotalamik hastalÄ±klar</strong></li>
</ul></li>
</ul>
</section>

<section id="pitÃ¼iter-adenom-patogenezi" class="title-slide slide level1 center">
<h1>PitÃ¼iter adenom patogenezi</h1>
<ul>
<li><strong>Guanine nucleotideâbinding protein (G protein) mutasyonlarÄ±</strong></li>
<li><strong>Sinyal iletiminde kritik rolÃ¼ var</strong>
<ul>
<li><strong>YÃ¼zey reseptÃ¶rlerden (growth hormoneâreleasing hormone receptor) intraselÃ¼ler efektÃ¶rlere (adenyl cyclase)</strong>
<ul>
<li><strong>Sekonde mesajcÄ±lar (cAMP).</strong></li>
</ul></li>
<li><strong>GNAS1 geni ile kodalnÄ±r</strong></li>
</ul></li>
<li><strong>GNAS1 mutasyonu</strong>
<ul>
<li><strong>Somatotrop hÃ¼cre adenomlarÄ±nÄ±n %40</strong></li>
<li><strong>Kortikotrop hÃ¼cre adenomlarÄ±nÄ±n kÃ¼Ã§Ã¼k bir kÄ±smÄ±</strong></li>
</ul></li>
</ul>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B17.png" class="r-stretch"></section>

<section id="hipofiz-adenomu-patogenezi" class="title-slide slide level1 center">
<h1>Hipofiz adenomu patogenezi</h1>
<ul>
<li><strong>Ailesel hipofiz adenomlarÄ±</strong>
<ul>
<li><strong>MEN1, CDKN1B, PRKAR1A, and AIP</strong></li>
<li><strong>MEN1 geninde germline inaktivasyon mutasyonlarÄ±</strong>
<ul>
<li><strong>multiple endocrine neoplasia syndrome type 1 (MEN-1)</strong></li>
</ul></li>
<li><strong>CDKN1B gene</strong>
<ul>
<li><strong>HÃ¼cre siklusunda dÃ¼zenleyici p27 or KIP1</strong></li>
</ul></li>
<li><strong>CDKN1B germline mutasyonlar</strong>
<ul>
<li><strong>âMEN-1 benzeriâ sendrom</strong></li>
</ul></li>
<li><strong>Aryl hydrocarbon receptorâinteracting protein (AIP)</strong>
<ul>
<li><strong>Hipofiz adenom yatkÄ±nlÄ±k geni</strong></li>
<li><strong>&lt;35 yaÅ, GH adenomu</strong></li>
</ul></li>
</ul></li>
<li><strong>TP53 mutasyonlarÄ±</strong>
<ul>
<li><strong>Agresif davranÄ±Å, invazyon ve rekÃ¼rrensle iliÅkili</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B18.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B19.png"></p>
<p><strong>Makroadenom&gt;1 cm</strong></p>
<p><strong>Mikroadenom&lt;1 cm</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B110.png"></p>
<p><strong>Ä°yi sÄ±nÄ±rlÄ±, yumuÅak kÄ±vamlÄ± lezyon</strong></p>
<p><strong>KÃ¼Ã§Ã¼k tÃ¼mÃ¶rler, sella turcica sÄ±nÄ±rlÄ±</strong></p>
<p><strong>Ä°ri tÃ¼mÃ¶rle optik kiazma ve komÅu yapÄ±lara baskÄ± uygular</strong></p>
<p><strong>Sella turcia ve clinoid proses erezyonu</strong></p>
<p><strong>KavernÃ¶z ve sifenoid sinÃ¼slere uzanÄ±m</strong></p>
<p><strong>%30 olguda kapsÃ¼lsÃ¼z, kemik, dura ve nadiren beyin invazyonu</strong></p>
<p><strong>Kanama ve nekroz bÃ¼yÃ¼k iri adenomlarda sÄ±k</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B111.png"></p>
<p><strong>Masif, nonfonksiyone adenom, sella turcicayÄ± aÅÄ±p beyne basÄ± uygulamÄ±Å</strong></p>
<p><strong>Nonfonksiyone adenomlar tanÄ± anÄ±nda fonksiyone adenomlara kÄ±yasla daha iri olurlar</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B112.png"></p>
<p><strong>Uniform poligonal hÃ¼creler, tabaka, kord veya papiller gÃ¶rÃ¼nÃ¼mde</strong></p>
<p><strong>Destekleyici konnektif doku ya da retikÃ¼lin Ã§ok az</strong></p>
<p><strong>YumuÅak, jelatinÃ¶z kÄ±vam</strong></p>
<p><strong>NÃ¼kleuslar uniform ya da pleomorfik</strong></p>
<p><strong>Mitotik aktivite genelde Ã§ok nadir</strong></p>
<p><strong>Sitoplazma asidofilik, bazofilik ya da kromofobik olabilir, ancak tÃ¼mÃ¶r boyunca homojendir</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>anterior hipofiz parankimi</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B113.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B114.png"></p>
<p><strong>HÃ¼cresel monomorfizm ve retikÃ¼lin aÄÄ±nÄ±n olmamamsÄ± ile hipofiz adenomu Ã§evre nonneoplastik adenohipofiz dokusundan ayrÄ±labilir</strong></p>
</section>

<section id="hipofiz-adenomu" class="title-slide slide level1 center">
<h1>Hipofiz adenomu</h1>
<ul>
<li><strong>Histolojik inceleme ile fonksiyonel durum gÃ¼venle tahmin edilemeyebilir</strong></li>
<li><strong>TP53 mutasyonu gÃ¶steren adenomlar</strong>
<ul>
<li><strong>Belirgin mitotik aktivite</strong></li>
<li><strong>YÃ¼ksek proliferasyon hÄ±zÄ±</strong></li>
<li><strong>âAtipik adenomâ diye adlandÄ±rÄ±lÄ±rlar</strong></li>
<li><strong>Agresif davranÄ±Å potansiyeli var</strong></li>
</ul></li>
<li><strong>Genelde tek hÃ¼cre tipinden oluÅur ve tek tip hormon Ã¼retirler</strong></li>
<li><strong>BazÄ± adenomlar iki farklÄ± hormon sekrete edebilir</strong>
<ul>
<li><strong>GH ve PRL en sÄ±k kombinasyon</strong></li>
<li><strong>Nadiren plurihormonal</strong></li>
</ul></li>
<li><strong>Fonksiyonel</strong>
<ul>
<li><strong>Hormon fazlalaÄ±ÄÄ± ve klinik bulgularÄ±</strong></li>
</ul></li>
<li><strong>Nonfonksiyone adenomlar</strong>
<ul>
<li><strong>Kitle etkisi, hipopitÃ¼itarizm</strong></li>
<li><strong>Hormon ekspresyonu sadece dokuda, immÃ¼nohistokimya ile gÃ¶sterilebilir, klinik bulgu yoktur</strong></li>
</ul></li>
<li><strong>GerÃ§ek âhormon negatifâ</strong>
<ul>
<li><strong>Ä°mmÃ¼nohistokimyasal olarak ya da ultrastrÃ¼ktÃ¼ler olarak hormon Ã¼retimi yok</strong></li>
</ul></li>
<li><strong>Nonfonksiyone ve hormon negatif adenomlar</strong>
<ul>
<li><strong>GeÃ§ klinik bulgu verirler</strong></li>
<li><strong>Makroadenom</strong></li>
<li><strong>HipopitÃ¼itarizm</strong></li>
</ul></li>
</ul>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B115.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="prolaktinom" class="title-slide slide level1 center">
<h1>Prolaktinom</h1>
<p><strong>En sÄ±k hiperfonksiyon gÃ¶steren adenom</strong></p>
<p><strong>KÃ¼Ã§Ã¼k mikroadenom, bÃ¼yÃ¼k kitle etkisi yapabilen adenomlara kadar deÄiÅken bÃ¼yÃ¼klÃ¼k</strong></p>
<p><strong>PRL immÃ¼nohistokimyasal olarak gÃ¶sterilebilir</strong></p>
</section>

<section id="hiperprolaktinemi" class="title-slide slide level1 center">
<h1>Hiperprolaktinemi</h1>
<ul>
<li><strong>Amenore, Galaktore, libido kaybÄ±, infertilite</strong></li>
<li><strong>DoÄurganlÄ±k Ã§aÄÄ±ndaki kadÄ±nlarda erken dÃ¶nemde tespit edilir</strong></li>
<li><strong>Erkeklerde ve ileri yaÅ kadÄ±nlarda daha az klinik bulgu</strong>
<ul>
<li><strong>Adenom bÃ¼yÃ¼klÃ¼ÄÃ¼ tanÄ± sÄ±rasÄ±nda daha bÃ¼yÃ¼k</strong></li>
</ul></li>
<li><strong>PRL-adenomu dÄ±ÅÄ± nedenler:</strong>
<ul>
<li><strong>Gebelik</strong></li>
<li><strong>YÃ¼ksek doz Ã¶strojen tedavisi</strong></li>
<li><strong>BÃ¶brek yetmezliÄi</strong></li>
<li><strong>Hipotiroidi</strong></li>
<li><strong>Hipotalamik lezyonlar</strong></li>
<li><strong>Dopamin inhibitÃ¶rleri (reserpine)</strong></li>
<li><strong>Sap (stalk) etkisi</strong>
<ul>
<li><strong>Hipotalamusun inhibitÃ¶r etkisini kaldÄ±racak kitle etkisi</strong></li>
<li><strong>Serum PRL dÃ¼zeyindeki hafif yÃ¼kselmeler (&lt;200 Âµg/L) PRL dÄ±ÅÄ± baÅka hipofiz adenomlarÄ±nda da olabilir</strong></li>
</ul></li>
</ul></li>
</ul>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B116.png" class="r-stretch"><p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="somatotrop-bÃ¼yÃ¼me-hormonu-growth-hormone-adenomlarÄ±" class="title-slide slide level1 center">
<h1>Somatotrop (bÃ¼yÃ¼me hormonu / growth hormone) adenomlarÄ±</h1>
<ul>
<li><strong>En sÄ±k ikinci fonksiyonel adenom</strong>
<ul>
<li><strong>GH adenomu</strong></li>
<li><strong>Mikst GH+PRL adenomu</strong></li>
</ul></li>
<li><strong>Klinik bulgular hafif olabilir</strong></li>
<li><strong>Klinik bulgu verdiÄinde oldukÃ§a bÃ¼yÃ¼k olabilir</strong></li>
<li><strong>GH immÃ¼nohistokimya ile gÃ¶sterilebilir</strong>
<ul>
<li><strong>Az miktarda PRL ekspresyonu da eÅlik edebilir</strong></li>
</ul></li>
<li><strong>SÃ¼rekli GH sekresyonu</strong>
<ul>
<li><strong>Hepatositlerden insulin-like growth factor I (somatomedin C) salgÄ±lanmasÄ±</strong>
<ul>
<li><strong>Klinik bulgulara neden olur</strong></li>
</ul></li>
</ul></li>
<li><strong>Epifiz hattÄ± kapanmadan, prepÃ¼berte</strong>
<ul>
<li><strong>Gigantizm (Devlik)</strong>
<ul>
<li><strong>VÃ¼cut boyutlarÄ±nda jeneralize artÄ±Å</strong></li>
<li><strong>Kol ve bacaklarda uygunsuz boy</strong></li>
</ul></li>
</ul></li>
<li><strong>Epifiz hattÄ± kapandÄ±ktan sonra</strong>
<ul>
<li><strong>Akromegali</strong>
<ul>
<li><strong>YumuÅak doku, deri, organlar ve el, ayak, yÃ¼z kemiklerinde bÃ¼yÃ¼me</strong></li>
<li><strong>Prognatizm</strong>
<ul>
<li><strong>Ãenede irileÅme ve Ã¶ne Ã§Ä±kma</strong></li>
<li><strong>YÃ¼zÃ¼n alt tarfÄ±nda geniÅleme ve diÅlerde ayrÄ±lma</strong></li>
</ul></li>
<li><strong>El ve ayaklarda geniÅleme</strong></li>
<li><strong>Iri, sosis gibi parmaklar</strong></li>
</ul></li>
</ul></li>
<li><strong>Growth hormone fazlalÄ±ÄÄ±</strong>
<ul>
<li><strong>Anormal glukoz toleransÄ±</strong></li>
<li><strong>diabetes mellitus</strong></li>
<li><strong>Jeneralize kas gÃ¼Ã§sÃ¼zlÃ¼ÄÃ¼</strong></li>
<li><strong>Hipertansiyon</strong></li>
<li><strong>Artrit</strong></li>
<li><strong>Osteoporoz</strong></li>
<li><strong>Konjestif Kalp YetmezliÄi</strong></li>
</ul></li>
</ul>
</section>

<section id="kortikotrop-acth-Ã¼reten-adenomlar" class="title-slide slide level1 center">
<h1>Kortikotrop (ACTH Ã¼reten) adenomlar</h1>
<ul>
<li><p><strong>ÃoÄu tanÄ± anÄ±nda kÃ¼Ã§Ã¼k, mikroadenom</strong></p></li>
<li><p><strong>PAS pozitif</strong></p>
<ul>
<li><strong>Glikolize ACTH birikimi nedeniyle</strong></li>
</ul></li>
<li><p><strong>ImmÃ¼nohistokimya ile ACTH ekspresyonu</strong></p></li>
<li><p><strong>Elektron mikroskobu ile, membrana baÄlÄ± elektron yoÄun granÃ¼ller (300nm Ã§ap)</strong></p></li>
<li><p><strong>Klinik olarak sessiz</strong></p></li>
<li><p><strong>Hiperkortizolizm</strong></p>
<ul>
<li><strong>Cushing sendromu</strong></li>
<li><strong>ACTHâÄ±n adrenal korteks Ã¼zerindeki uyarÄ±cÄ± etkileri</strong></li>
</ul></li>
<li><p><strong>Cushing hastalÄ±ÄÄ±</strong></p>
<ul>
<li><strong>EÄer artmÄ±Å ACTH hipofiz kaynaklÄ± ise</strong></li>
</ul></li>
<li><p><strong>Nelson sendromu</strong></p>
<ul>
<li><strong>Cushing sendromu tedavisi iÃ§in cerrahi olarak adrenallerin alÄ±nmasÄ± sonrasÄ± geliÅen iri, klinik agresif kortikotrop adenomu</strong></li>
<li><strong>Adrenaller alÄ±ndÄ±ÄÄ±nda â daha Ã¶nce var olan mikroadenom Ã¼zerindeki geri bildirim kalkar</strong></li>
<li><strong>Kitle etkisi</strong></li>
</ul></li>
</ul>
</section>

<section id="gonadotrop-fsh-ya-da-lh-adenomlarÄ±" class="title-slide slide level1 center">
<h1>Gonadotrop (FSH ya da LH) adenomlarÄ±</h1>
<p><strong>Tespiti zor</strong></p>
<p><strong>HormonlarÄ± dÃ¼zensiz ve az salgÄ±lar</strong></p>
<p><strong>Hormonlar klinik sendroma yol aÃ§mazlar</strong></p>
<p><strong>Kitle etkisi</strong></p>
<p><strong>Ä°mmÃ¼nohistokimyasal oalrak ortak gonadotropin Î±-subunit, spesifik Î²-FSH ve Î²-LH subunits</strong></p>
<p><strong>FSH genelde daha baskÄ±n</strong></p>
</section>

<section id="tirotrop-tsh-adenomlarÄ±" class="title-slide slide level1 center">
<h1>Tirotrop (TSH) adenomlarÄ±</h1>
<p><strong>Hipofiz adenomlarÄ±nÄ±n %1âi</strong></p>
<p><strong>Hipertiroidizm</strong></p>
</section>

<section id="nonfonksiyone-adenomlar" class="title-slide slide level1 center">
<h1>Nonfonksiyone adenomlar</h1>
<ul>
<li><strong>Hipofiz adenomlarÄ±nÄ±n %25âi</strong></li>
<li><strong>Kitle etkisi</strong></li>
<li><strong>HipopitÃ¼itarizm</strong></li>
<li><strong>Klinik sakin fonksiyone adenomlar</strong>
<ul>
<li><strong>Sessiz gonadotrop adenomu</strong></li>
</ul></li>
<li><strong>GerÃ§ek hormon negatif (null cell) adenom</strong></li>
</ul>
</section>

<section id="hipofiz-karsinomlarÄ±" class="title-slide slide level1 center">
<h1>Hipofiz karsinomlarÄ±</h1>
<p><strong>Ãok nadir</strong></p>
<p><strong>Lokal invazyon</strong></p>
<p><strong>Uzak metastaz</strong></p>
</section>

<section id="hipopitÃ¼itarizm" class="title-slide slide level1 center">
<h1>HipopitÃ¼itarizm</h1>
<p><strong>Anterior lob parankiminin %75âinden fazlasÄ±nda kayÄ±p</strong></p>
<p><strong>Konjenital (Ã§ok nadir)</strong></p>
<p><strong>Nonfonksiyone hipofiz adenomu</strong></p>
<ul>
<li><p><strong>Anterior hipofizde iskemik nekroz</strong></p>
<ul>
<li><strong>Sheehan sendromu</strong>
<ul>
<li><strong>DoÄum sonrasÄ± nekroz</strong></li>
<li><strong>Gebelik sÄ±rasÄ±nda bezde fizyolojik geniÅleme</strong></li>
<li><strong>Bu geniÅlemeye venÃ¶z portal sistem eÅlik etmez</strong></li>
<li><strong>Ani kan kaybÄ± ve hipotansiyon iskemiye neden olur</strong></li>
<li><strong>NÃ¶rohipofiz etkilenmez, beslenmesi arteryal</strong></li>
</ul></li>
<li><strong>Dissemine intravaskÃ¼ler koagÃ¼lasyon</strong></li>
<li><strong>Orak hÃ¼creli anemi</strong></li>
<li><strong>ArtmÄ±Å intrakraniyel basÄ±nÃ§</strong></li>
<li><strong>Travma</strong></li>
<li><strong>Åok</strong></li>
</ul></li>
<li><p><strong>RezidÃ¼ bez bÃ¼zÃ¼ÅmÃ¼Å ve skar</strong></p></li>
<li><p><strong>Cerrahi ,radyasyon</strong></p></li>
<li><p><strong>Ä°nflamasyon</strong></p>
<ul>
<li><strong>Sarkoidoz, tÃ¼berkÃ¼loz</strong></li>
</ul></li>
<li><p><strong>Travma</strong></p></li>
<li><p><strong>Metastaz</strong></p></li>
</ul>
</section>

<section id="clinical-manifestations-of-anterior-pituitary-hypofunction" class="title-slide slide level1 center">
<h1>Clinical manifestations of anterior pituitary hypofunction</h1>
<ul>
<li><strong>Depend on the specific hormones that are lacking</strong></li>
<li><strong>Growth hormone deficiency</strong>
<ul>
<li><strong>Growth failure (pituitary dwarfism)</strong></li>
</ul></li>
<li><strong>Gonadotropin or gonadotropin-releasing hormone (GnRH) deficiency</strong>
<ul>
<li><strong>amenorrhea and infertility in women</strong></li>
<li><strong>decreased libido, impotence, and loss of pubic and axillary hair in men</strong></li>
</ul></li>
<li><strong>TSH</strong>
<ul>
<li><strong>hypothyroidism</strong></li>
</ul></li>
<li><strong>ACTH</strong>
<ul>
<li><strong>hypoadrenalism</strong></li>
</ul></li>
<li><strong>Prolactin deficiency</strong>
<ul>
<li><strong>failure of postpartum lactation</strong></li>
</ul></li>
<li><strong>Loss of stimulatory effects of MSH on melanocytes</strong>
<ul>
<li><strong>Pallor</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B117.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B118.jpg"></p>
</section>

<section id="posterior-hipofiz-sendromlari" class="title-slide slide level1 center">
<h1>POSTERIOR HIPOFIZ SENDROMLARI</h1>

</section>

<section id="posterior-pituitary-syndromes" class="title-slide slide level1 center">
<h1>Posterior Pituitary Syndromes</h1>
<ul>
<li><strong>Neurohypophysis</strong>
<ul>
<li><strong>composed of modified glial cells (termed pituicytes )</strong></li>
<li><strong>Axonal processes extending from nerve cell bodies in the supraoptic and paraventricular nuclei of the hypothalamus</strong></li>
</ul></li>
<li><strong>Hypothalamic neurons produce two peptides</strong>
<ul>
<li><strong>antidiuretic hormone (ADH) and oxytocin</strong></li>
<li><strong>They are stored in axon terminals in the neurohypophysis</strong></li>
<li><strong>Released into the circulation in response to stimuli</strong></li>
</ul></li>
<li><strong>Oxytocin</strong>
<ul>
<li><strong>stimulates the contraction of smooth muscle in the pregnant uterus</strong></li>
<li><strong>muscle surrounding the lactiferous ducts of the mammary glands</strong></li>
<li><strong>Impairment of oxytocin synthesis and release has not been associated with significant clinical abnormalities</strong></li>
</ul></li>
<li><strong>ADH</strong>
<ul>
<li><strong>diabetes insipidus</strong></li>
<li><strong>secretion of inappropriately high levels of ADH</strong></li>
</ul></li>
</ul>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B119.jpg" class="r-stretch"></section>

<section id="antidiÃ¼retik-hormon" class="title-slide slide level1 center">
<h1>AntidiÃ¼retik hormon</h1>
<ul>
<li><strong>Supraoptik nÃ¼kleus kaynaklÄ± nanopeptid</strong></li>
<li><strong>ADH sekresyon nedenleri</strong>
<ul>
<li><strong>ArtmÄ±Å plazma onkositik basÄ±ncÄ±, sol atrial dilatasyonu, egzersiz, duygusal stres</strong></li>
<li><strong>BÃ¶brek toplayÄ±cÄ± duktuslarÄ±ndan su emilimi</strong></li>
</ul></li>
<li><strong>ADH eksikliÄi diabetes insipidus</strong>
<ul>
<li><p><strong>PoliÃ¼ri</strong></p></li>
<li><p><strong>BÃ¶brek idrardan suyu yeterli miktarda ememez</strong></p></li>
<li><p><strong>Uygunsuz ADH sekresyonu (SIADH)</strong></p>
<ul>
<li><strong>Fazla su emilimi</strong></li>
<li><strong>Hiponatremi, serebral Ã¶dem, nÃ¶rolojik disfonksiyon</strong></li>
</ul></li>
<li><p><strong>ADH fazlalÄ±ÄÄ± nedenleri:</strong></p>
<ul>
<li><strong>Paraneoplastik</strong>
<ul>
<li><strong>KÃ¼Ã§Ã¼k hÃ¼creli akciÄer kanseri</strong></li>
</ul></li>
<li><strong>Nonneoplastik akciÄer hastalÄ±klarÄ±</strong></li>
<li><strong>Hipotalamus veya hipofize lokal hasar</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="hipotalamik-suprasellar-tÃ¼mÃ¶rler" class="title-slide slide level1 center">
<h1>HIPOTALAMIK SUPRASELLAR TÃMÃRLER</h1>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B120.png" class="r-stretch"><p><strong>Kraniyofarenjiom</strong></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

<section id="kraniyofarenjiom" class="title-slide slide level1 center">
<h1>Kraniyofarenjiom</h1>
<ul>
<li><p><strong>Rathke kesesi artÄ±klarÄ±</strong></p></li>
<li><p><strong>Ä°ntrakraniyel tÃ¼mÃ¶rlerin %1-5</strong></p></li>
<li><p><strong>ÃoÄu suprasellar, intrasellar uzanÄ±m olabilir</strong></p></li>
<li><p><strong>Bimodal yaÅ daÄÄ±lÄ±mÄ±</strong></p>
<ul>
<li><strong>5-15 yaÅ</strong></li>
<li><strong>&gt;65 yaÅ</strong></li>
</ul></li>
<li><p><strong>WNT yolaÄÄ±, Î²-catenin mutasyonlarÄ±</strong></p></li>
<li><p><strong>Ortalama Ã§ap 3-4 â¯cm</strong></p></li>
<li><p><strong>Sistik ve bazen multilokÃ¼le</strong></p></li>
<li><p><strong>AdamantinomatÃ¶z Kraniyofarenjiom</strong></p>
<ul>
<li><strong>Ãocuklarda</strong></li>
<li><strong>Kalsifikasyon</strong></li>
<li><strong>Kistleri kolesterolden zengin, kahverengi-sarÄ± sÄ±vÄ± (makine yaÄÄ±)</strong></li>
</ul></li>
<li><p><strong>Papiller Kraniyofarenjiom</strong></p>
<ul>
<li><strong>EriÅkinlerde</strong></li>
</ul></li>
</ul>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B121.png" class="r-stretch"><p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>

<section id="section" class="title-slide slide level1 center">
<h1></h1>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B122.png" class="r-stretch"></section>

<section id="hipofiz-adenomuna-yaklaÅÄ±m" class="title-slide slide level1 center">
<h1>Hipofiz adenomuna yaklaÅÄ±m</h1>

</section>

<section id="dr.-serdar-balcÄ±" class="title-slide slide level1 center">
<h1>Dr.&nbsp;Serdar BalcÄ±</h1>

</section>

<section id="klinik-bilgi" class="title-slide slide level1 center">
<h1>Klinik bilgi</h1>
<ul>
<li><strong>Ãocuklarda: PRL, ACTH</strong></li>
<li><strong>Hormon dÃ¼zeylerinde artÄ±Å</strong>
<ul>
<li><strong>Hiperprolaktinemi â nonspesifik</strong></li>
</ul></li>
<li><strong>Kitle etkisi</strong>
<ul>
<li><strong>BaÅaÄrÄ±sÄ±</strong></li>
<li><strong>GÃ¶rme alanÄ±</strong></li>
<li><strong>Hipopituitarism</strong></li>
</ul></li>
<li><strong>D. insipid ve kraniel sinir arazÄ±</strong>
<ul>
<li><strong>Ãncelikle diÄer tÃ¼mÃ¶rler, metastazlar</strong></li>
<li><strong>Ä°nflamatuar sÃ¼reÃ§ler</strong></li>
</ul></li>
</ul>
</section>

<section id="ameliyat" class="title-slide slide level1 center">
<h1>Ameliyat</h1>
<p><strong>EÄer hemen patolojiye gelecekse SF iÃ§eren tÃ¼pte gÃ¶nderilebilir. (Otoliz, formolsÃ¼z diye not konan rapor sayÄ±sÄ±)</strong></p>
<p><strong>GazlÄ± bezi unutun</strong></p>
<p><strong>Formaldehit</strong></p>
<p><strong>EM inceleme?</strong></p>
</section>

<section id="hipofiz-adenomu---frozen" class="title-slide slide level1 center">
<h1>Hipofiz adenomu - Frozen</h1>
<ul>
<li><strong>Doku genelde kÃ¼Ã§Ã¼k</strong>
<ul>
<li><strong>Donma artefaktÄ±</strong></li>
</ul></li>
<li><strong>Yayma</strong>
<ul>
<li><strong>Daha az doku yeterli</strong></li>
<li><strong>Deneyim gerektiriyor</strong></li>
</ul></li>
<li><strong>Tek tanÄ±sal materyal frozenda </strong> <em>harcanmÄ±Å </em> <strong>olabilir</strong></li>
<li><strong>Frozen beklenmedik bir bulgu ile karÅÄ±laÅÄ±nca uygulanabilir (baÅka tÃ¼mÃ¶r ÅÃ¼phesi)</strong></li>
<li><strong>Ä°ntraoperatif retikÃ¼lin?</strong></li>
<li><strong>Cerrahi sÄ±nÄ±r?</strong></li>
</ul>
</section>

<section id="mikroadenom-frozen" class="title-slide slide level1 center">
<h1>Mikroadenom â Frozen?</h1>

</section>

<section id="adenohipofiz-1" class="title-slide slide level1 center">
<h1>Adenohipofiz</h1>
<p><strong>LobÃ¼ler yapÄ±</strong></p>
<p><strong>CoÄrafi daÄÄ±lÄ±m</strong></p>
<p><strong>TÃ¼krÃ¼k bezi benzeri bezler gibi taklitÃ§iler</strong></p>
</section>

<section id="ara-lob" class="title-slide slide level1 center">
<h1>Ara lob???</h1>

</section>

<section id="nÃ¶rohipofiz" class="title-slide slide level1 center">
<h1>NÃ¶rohipofiz</h1>

</section>

<section id="suprasellar-kitleler---ddx" class="title-slide slide level1 center">
<h1>Suprasellar kitleler - Ddx</h1>
<p><strong>Pituisitom</strong></p>
<p><strong>Lenfositik/granÃ¼lamatÃ¶z hipofizit</strong></p>
<p><strong>Lenfoma</strong></p>
<p><strong>Gangliositom/Gangliositoadenom</strong></p>
<p><strong>Germ hÃ¼creli tÃ¼mÃ¶rler</strong></p>
<p><strong>GranÃ¼ler hÃ¼crrli tÃ¼mÃ¶r</strong></p>
<p><strong>Plazmasitom</strong></p>
<p><strong>Lenfoma</strong></p>
<p><strong>Paragangliom</strong></p>
<p><strong>Metastaz</strong></p>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B123.png" class="r-stretch"></section>

<section id="section-1" class="title-slide slide level1 center">
<h1></h1>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B124.png" class="r-stretch"></section>

<section id="sellar-kitleler" class="title-slide slide level1 center">
<h1>Sellar kitleler</h1>
<p><strong>Kraniyofarengiom</strong></p>
<p><strong>Rathke kleft kisti</strong></p>
<p><strong>Teratom</strong></p>
<p><strong>Kordoma</strong></p>
<p><strong>Germinom</strong></p>
<p><strong>Pilositik astrositom</strong></p>
<p><strong>Lenfoma</strong></p>
<p><strong>Ä°nflamasyon</strong></p>
<p><strong>Langerhans hÃ¼creli histiyositoz</strong></p>
<p><strong>GranÃ¼ler hÃ¼creli tÃ¼mÃ¶r</strong></p>
<p><strong>Glezer et al, Rare Sellar Lesions, Endocrinol Metab Clin N Am 37 (2008) 195â211</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B125.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B126.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B127.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B128.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B129.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B130.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B131.jpg"></p>
</section>

<section id="section-2" class="title-slide slide level1 center">
<h1></h1>
<p><strong>Postmortem prevalence of pituitary adenoma is 14.4% </strong></p>
<p><strong>radiologic studies identify a lesion consistent with pituitary adenoma in 22.2% of the population</strong></p>
<p><strong>providing an overall estimated prevalence of 16.9%.</strong></p>
</section>

<section id="adenom---hiperplazi" class="title-slide slide level1 center">
<h1>Adenom - Hiperplazi</h1>
<ul>
<li><strong>DiffÃ¼z, nodÃ¼ler</strong></li>
<li><strong>Hiperplazi</strong>
<ul>
<li><strong>Stimulus kesilince bÃ¼yÃ¼me durur</strong></li>
<li><strong>Gebelik: laktotrop hÃ¼cre proliferasyonu</strong></li>
<li><strong>Primer hipopituitarizm: tirotrop</strong></li>
<li><strong>Hipotalamik gangliositom, GHrH eksprese eden tÃ¼mÃ¶rler: somatotrop</strong></li>
<li>__ CrH: bronÅial, gastroenterohepatik, adrenal, prostat endokrin tÃ¼mÃ¶rler__</li>
</ul></li>
</ul>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B132.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B133.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B134.png"></p>
</section>

<section id="hipofiz-adenomu-1" class="title-slide slide level1 center">
<h1>Hipofiz adenomu</h1>

</section>

<section id="ffpe-he" class="title-slide slide level1 center">
<h1>FFPE â H&amp;E</h1>
<ul>
<li><strong>H&amp;E</strong></li>
<li><strong>10 boyasÄ±z</strong>
<ul>
<li><strong>RetikÃ¼lin</strong></li>
<li><strong>PAS?</strong></li>
<li><strong>MIB-1</strong></li>
<li><strong>p53</strong></li>
<li><strong>Hormonlar</strong></li>
</ul></li>
</ul>
<p><strong>NÃ¼kleus</strong></p>
<p><strong>NÃ¼kleol</strong></p>
<p><strong>Kromatin</strong></p>
<p><strong>Atipi?</strong></p>
<p><strong>Mitoz</strong></p>
<p><strong>Sitoplazma</strong></p>
<p><strong>YapÄ±</strong></p>
<p><strong>Papiller</strong></p>
<p><strong>Amiloid</strong></p>
<p><strong>Kalsifikasyon</strong></p>
<p><strong>Tedavi etkisi</strong></p>
</section>

<section id="retikÃ¼lin-adenohipofiz-hiperplazi-adenom" class="title-slide slide level1 center">
<h1>RetikÃ¼lin: Adenohipofiz, Hiperplazi, Adenom</h1>

</section>

<section id="hormon-belirteÃ§leri" class="title-slide slide level1 center">
<h1>Hormon belirteÃ§leri</h1>

</section>

<section id="gh" class="title-slide slide level1 center">
<h1>GH</h1>

</section>

<section id="gh-ck8" class="title-slide slide level1 center">
<h1>GH â CK8</h1>

</section>

<section id="prolaktin" class="title-slide slide level1 center">
<h1>Prolaktin</h1>

</section>

<section id="prolaktin-ck8" class="title-slide slide level1 center">
<h1>Prolaktin â CK8</h1>

</section>

<section id="tsh" class="title-slide slide level1 center">
<h1>TSH</h1>

</section>

<section id="fsh" class="title-slide slide level1 center">
<h1>FSH</h1>

</section>

<section id="lh" class="title-slide slide level1 center">
<h1>LH</h1>

</section>

<section id="acth" class="title-slide slide level1 center">
<h1>ACTH</h1>

</section>

<section id="acth---mikroadenom" class="title-slide slide level1 center">
<h1>ACTH - mikroadenom</h1>
<p><strong>RetikÃ¼lin ve ACTH IHKâsÄ± gerekli</strong></p>
<p><strong>YoÄun granÃ¼llÃ¼</strong></p>
<p><strong>Bazofilik hÃ¼creler</strong></p>
<p><strong>PAS +</strong></p>
<p><strong>CAM 5.2, CK7, CK8</strong></p>
</section>

<section id="acth--crooke-deÄiÅiklik" class="title-slide slide level1 center">
<h1>ACTH- Crooke deÄiÅiklik</h1>
<ul>
<li><strong>TÃ¼mÃ¶rsÃ¼z alanda (genellikle kortikotroplarda)</strong></li>
<li><strong>DolaÅÄ±mdaki artmÄ±Å glukokortikoid varlÄ±ÄÄ±nÄ± yansÄ±tÄ±r</strong>
<ul>
<li><strong>Pituiter kortikotrop adenom</strong></li>
<li><strong>Ektopik ACTH sekresyonu</strong></li>
<li><strong>Primer adrenal patolojiler</strong></li>
<li><strong>Ä°atrojenik</strong></li>
</ul></li>
<li><strong>Adenom gÃ¶rÃ¼lmediyse mikroadenom varlÄ±ÄÄ± araÅtÄ±rÄ±lmalÄ± (1-2 mmâlik seri kesitler, retikÃ¼lin ve ACTH ile bakÄ±larak)</strong></li>
<li><strong>Adenom gÃ¶rÃ¼lmezse klinikopatolojik korelasyon gerektirir</strong></li>
</ul>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B135.png" class="r-stretch"></section>

<section id="acth--crooke-cell" class="title-slide slide level1 center">
<h1>ACTH- Crooke cell</h1>
<ul>
<li><strong>Adenom gÃ¶rÃ¼lmediyse mikroadenom varlÄ±ÄÄ± araÅtÄ±rÄ±lmalÄ±</strong>
<ul>
<li><strong>1-2 mmâlik seri kesitler</strong></li>
<li><strong>RetikÃ¼lin ve ACTH ile bakÄ±larak</strong></li>
</ul></li>
<li><strong>Adenom gÃ¶rÃ¼lmezse klinikopatolojik korelasyon gerektirir</strong>
<ul>
<li><strong>HÃ¢lÃ¢ sellada adenom var mÄ±?</strong></li>
<li><strong>Kortikoid yÃ¼ksekliÄinin baÅka nedenleri</strong></li>
<li><strong>AspiratÃ¶rde ya da seri kesitlerde kaybolan adenom?</strong></li>
</ul></li>
</ul>
</section>

<section id="acth-crooke-deÄiÅiklik-yok-adenom-yok" class="title-slide slide level1 center">
<h1>ACTH Crooke deÄiÅiklik yok, adenom yok</h1>
<ul>
<li><strong>Kortikotrop hiperplazi?</strong>
<ul>
<li><strong>Patolojik deÄerlendirme zor olabilir</strong></li>
</ul></li>
<li><strong>PsÃ¶do Cushing</strong></li>
</ul>
</section>

<section id="acth-crooke-cell-adenoma" class="title-slide slide level1 center">
<h1>ACTH â Crooke cell adenoma</h1>
<p><strong>AdenomatÃ¶z hÃ¼crelerin sitoplazmasÄ±nda yoÄun birikim</strong></p>
<p><strong>NÃ¼kleer pleomorfizm, iri hÃ¼cre</strong></p>
<p><strong>DDX: gangliositom, metastaz</strong></p>
<p><strong>ACTH +</strong></p>
<p><strong>YoÄun halka Åeklinde keratin birikimi</strong></p>
<p><strong>CAM 5.2 +</strong></p>
</section>

<section id="p53" class="title-slide slide level1 center">
<h1>p53</h1>

</section>

<section id="ki-67" class="title-slide slide level1 center">
<h1>Ki-67</h1>

</section>

<section id="pit-1" class="title-slide slide level1 center">
<h1>Pit-1</h1>

</section>

<section id="er-Î±" class="title-slide slide level1 center">
<h1>ER-Î±</h1>

</section>

<section id="mukozada-ekilim" class="title-slide slide level1 center">
<h1>Mukozada ekilim?</h1>

</section>

<section id="serum-ihk-korelasyonu" class="title-slide slide level1 center">
<h1>Serum â IHK korelasyonu</h1>

</section>

<section id="otopside-inceleme" class="title-slide slide level1 center">
<h1>Otopside inceleme</h1>
<p><strong>Stalk yÃ¼ksekten kesilmeli</strong></p>
<p><strong>Sella kontrol edilmeli</strong></p>
<p><strong>Dorsum sella dan aÃ§Ä±larak intakt Ã§Ä±kartÄ±lmaya Ã§alÄ±ÅÄ±lmalÄ±</strong></p>

<img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B136.png" class="r-stretch"></section>

<section id="alÄ±ntÄ±-slaytlar" class="title-slide slide level1 center">
<h1>AlÄ±ntÄ± slaytlar</h1>

</section>

<section id="section-3" class="title-slide slide level1 center">
<h1></h1>

</section>

<section id="adenohipofiz-2" class="title-slide slide level1 center">
<h1>Adenohipofiz</h1>
<p><strong>Lateral kanat</strong></p>
<p><strong>Mukoid wedge</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B137.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B138.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B139.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B140.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B141.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B142.png"></p>
</section>

<section id="hipofiz-adenomu-sÄ±nÄ±flandÄ±rmasÄ±" class="title-slide slide level1 center">
<h1>Hipofiz adenomu sÄ±nÄ±flandÄ±rmasÄ±</h1>
<p><strong>Cerrahi, radyoloji</strong></p>
<ul>
<li><strong>Ä°nvazif</strong>
<ul>
<li><strong>Dura</strong></li>
<li><strong>Kemik</strong></li>
<li><strong>SinÃ¼sler</strong></li>
</ul></li>
<li><strong>Non-invazif</strong></li>
</ul>
<p><strong>Hormon aktif</strong></p>
<p><strong>Nonfonksiyone</strong></p>
<p><strong>Mikroadenom &lt;1cm</strong></p>
<p><strong>Makroadenom &gt;1cm</strong></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B143.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B144.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B145.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B146.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B147.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B148.jpg"></p>
</section>

<section id="bÃ¼yÃ¼me-hormonu-adenomu" class="title-slide slide level1 center">
<h1>BÃ¼yÃ¼me Hormonu Adenomu</h1>
<p><strong>%10</strong></p>
<p><strong>%25-30</strong></p>
<p><strong>Gigantizm, akromegali</strong></p>
<p><strong>Ä°nvaziv makroadenom</strong></p>
<p><strong>IGF-1</strong></p>
</section>

<section id="yoÄun-granÃ¼llÃ¼-gh-adenomu" class="title-slide slide level1 center">
<h1>YoÄun granÃ¼llÃ¼ GH adenomu</h1>
<p><strong>Yuvarlak, polihedral, asidofilik</strong></p>
<p><strong>YaygÄ±n, kuvvetli sitoplazmik GH</strong></p>
<p><strong>PerinÃ¼kleer CK8</strong></p>
<p><strong>YarÄ±sÄ±nda Î±-subÃ¼nit pozitif</strong></p>
<p><strong>Pit-1 kuvvetli nÃ¼kleer pozitif</strong></p>
<p><strong>EM sekretuvar granÃ¼ller bol</strong></p>
</section>

<section id="seyrek-granÃ¼llÃ¼-gh-adenomu" class="title-slide slide level1 center">
<h1>Seyrek granÃ¼llÃ¼ GH adenomu</h1>
<ul>
<li><p><strong>KÃ¼Ã§Ã¼k, yuvarlak, kÄ±smen dÃ¼zensiz hÃ¼creler</strong></p></li>
<li><p><strong>FibrÃ¶z cisimler</strong></p>
<ul>
<li><strong>ParanÃ¼kleer soluk asidofilik kÃ¼resel inklÃ¼zyon</strong></li>
<li><strong>LMWCK, CK8 pozitif</strong></li>
</ul></li>
<li><p><strong>Pleomorfizm, Ã§ok Ã§ekirdekli bizar hÃ¼creler</strong></p></li>
<li><p><strong>GH zayÄ±f sitoplazmik</strong></p></li>
<li><p><strong>Pit-1 kuvvetli nÃ¼kleer pozitif</strong></p></li>
<li><p><strong>Daha agresif</strong></p></li>
<li><p><strong>MultinÃ¼kleer, pleomorfizm</strong></p>
<ul>
<li><strong>Prognostik deÄil</strong></li>
</ul></li>
<li><p><strong>Makroadenom, invazif</strong></p></li>
<li><p><strong>Otokrin</strong></p>
<ul>
<li><strong>GHrH salgÄ±lÄ±yor</strong></li>
</ul></li>
</ul>
</section>

<section id="prl-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>PRL hÃ¼cre adenomu</h1>
<ul>
<li><strong>%25-30</strong></li>
<li><strong>Serum PRL dÃ¼zeyi genelde tÃ¼mÃ¶r boyutu ile paralel</strong>
<ul>
<li><strong>&gt;150ng/mL tanÄ±sal</strong></li>
<li><strong>Daha dÃ¼ÅÃ¼k deÄerler basÄ± etkisini yansÄ±tÄ±r</strong></li>
</ul></li>
<li><strong>KadÄ±nlarda mikroadenom Åeklinde</strong>
<ul>
<li><strong>Galaktore, amenore</strong></li>
</ul></li>
<li><strong>Erkeklerde</strong>
<ul>
<li><strong>Libido azalmasÄ±, impotans</strong></li>
</ul></li>
<li><strong>Mikroadenom lateral ve posteriorda</strong></li>
<li><strong>Genelde diffÃ¼z, nadiren papiller</strong></li>
<li><strong>Nadir iri, uzun hÃ¼creler, belirgin membran</strong></li>
</ul>
<p><strong>Amiloid depolanmasÄ±, kalsifikasyon</strong></p>
<p><strong>PitÃ¼iter taÅ</strong></p>
</section>

<section id="seyrek-granÃ¼llÃ¼-laktotrop-adenomu" class="title-slide slide level1 center">
<h1>Seyrek granÃ¼llÃ¼ laktotrop adenomu</h1>
<ul>
<li><strong>Kromofob, amfofilik</strong>
<ul>
<li><strong>Belirgin </strong> <em>rough</em> __ endoplazmik retikulum iÃ§erir__</li>
</ul></li>
<li><strong>ParanÃ¼kleer (golgi) paterninde PRL pozitif</strong></li>
<li><strong>Pit-1 nÃ¼kleer kuvvetli</strong></li>
</ul>
</section>

<section id="yoÄun-granÃ¼llÃ¼-laktotrop-adenomu" class="title-slide slide level1 center">
<h1>YoÄun granÃ¼llÃ¼ laktotrop adenomu</h1>
<p><strong>Nadir</strong></p>
</section>

<section id="dopamin-agonisti-tedavisi-etkisi" class="title-slide slide level1 center">
<h1>Dopamin agonisti tedavisi etkisi</h1>
<p><strong>Atrofi</strong></p>
<p><strong>HÃ¼cre boyutunda kÃ¼Ã§Ã¼lme</strong></p>
<p><strong>Sitoplazmada bÃ¼zÃ¼Åme</strong></p>
<p><strong>N/C oranÄ±nda artma</strong></p>
<p><strong>Ä°nterstisyel ve perivaskÃ¼ler fibrozis</strong></p>
</section>

<section id="tsh-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>TSH hÃ¼cre adenomu</h1>
<p><strong>Nadir</strong></p>
<p><strong>Ä°nvaziv</strong></p>
<p><strong>Solid, sinÃ¼zoidal patern</strong></p>
<p><strong>Stromal fibrozis, psammom cisimleri</strong></p>
<p><strong>HÃ¼cre sÄ±nÄ±rlarÄ± belirsiz kromofob adenom</strong></p>
<p><strong>NÃ¼kleer pleomorfizm olabilir</strong></p>
<p><strong>PAS sitoplazmik granÃ¼ller</strong></p>
<p><strong>Sitoplazma: Î±-subÃ¼nit, Î²-TSH</strong></p>
<p><strong>NÃ¼kleer Pit-1</strong></p>
<p><strong>Plurihormonal ekspresyon izlenebilir</strong></p>
</section>

<section id="acth-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>ACTH hÃ¼cre adenomu</h1>
<ul>
<li><strong>%10-15</strong></li>
<li><strong>Makroskopik: kÄ±rmÄ±zÄ± ve yumuÅak mikroadenom</strong></li>
<li><strong>Seri kesitlere raÄmen izlenemeyebilir</strong></li>
<li><strong>Nadir kavernÃ¶z sinÃ¼s invazyonu</strong>
<ul>
<li><strong>Klinik ve biyokimyasal semptom yok</strong></li>
<li><strong>Sessiz</strong></li>
</ul></li>
</ul>
<p><strong>DiffÃ¼z, sinÃ¼zoidal</strong></p>
<p><strong>Bazofilik, amfofilik, monomorfik, yuvarlak</strong></p>
<p><strong>Kuvvetli PAS pozitif</strong></p>
<p><strong>Crooke hyalen deÄiÅim</strong></p>
<p><strong>Pleomorfizm</strong></p>
<p><strong>Mitoz nadir</strong></p>
<p><strong>ACTH, Î²-LPH ve/veya Î²-endorfin</strong></p>
<p><strong>Cushing hastalÄ±ÄÄ± (pitÃ¼iter ACTH fazlalÄ±ÄÄ±)</strong></p>
<p><strong>Nelson zemininde geliÅen</strong></p>
<p><strong>Crooke cell adenoma</strong></p>
<p><strong>Sessiz kortikotrop adenomlar</strong></p>
</section>

<section id="cushing-hastalÄ±ÄÄ±-pitÃ¼iter-acth-fazlalÄ±ÄÄ±" class="title-slide slide level1 center">
<h1>Cushing hastalÄ±ÄÄ± (pitÃ¼iter ACTH fazlalÄ±ÄÄ±)</h1>

</section>

<section id="gonadotrop-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>Gonadotrop hÃ¼cre adenomu</h1>
<p><strong>Nadir?</strong></p>
<p><strong>Fonksiyonel olanlar erkeklerde daha sÄ±k</strong></p>
<p><strong>Sessiz adenomlarda IHK ile tanÄ± konur</strong></p>
<p><strong>Makroadenom</strong></p>
<p><strong>Supra, parasellar</strong></p>
<p><strong>SinÃ¼zoid, psÃ¶dorozet</strong></p>
<p><strong>Kanama, nekroz olabilir</strong></p>
<p><strong>PAS negatif, onkositik olabilir</strong></p>
<p><strong>Î±-subÃ¼nit, Î²-FSH (daha sÄ±k), Î²-LH pozitif</strong></p>
</section>

<section id="plurihormonal-adenomlar" class="title-slide slide level1 center">
<h1>Plurihormonal Adenomlar</h1>
<ul>
<li><strong>Pit-1</strong>
<ul>
<li><strong>KarÄ±ÅÄ±k somatotrop-laktotrop</strong>
<ul>
<li><strong>Akromegali, stalka basÄ±</strong></li>
<li><strong>Ä°ki farklÄ± hÃ¼cre tipi</strong></li>
</ul></li>
<li><strong>Mammosomatotrop</strong>
<ul>
<li><strong>Klinik sakin, akromegali, hiperPRL</strong></li>
<li><strong>AynÄ± hÃ¼crede GH ve PRL</strong></li>
</ul></li>
<li><strong>Asidofil kÃ¶k hÃ¼cre</strong>
<ul>
<li><strong>Klinik sakin veya hiperPRL</strong></li>
<li><strong>Kromofob</strong></li>
<li><strong>Ä°nvaziv</strong></li>
<li><strong>ParanÃ¼kleer vakuol</strong></li>
<li><strong>Agresif seyir</strong></li>
</ul></li>
<li><strong>Plurihormonal GH Ã¼reten adenomlar</strong>
<ul>
<li><strong>YoÄun granÃ¼llÃ¼ GH adenomu</strong></li>
<li><strong>PRL, Î±-subÃ¼nit, Î²-TSH, Î²-FSH, Î²-LH</strong></li>
</ul></li>
</ul></li>
<li><strong>ACTH-Î± subÃ¼nit</strong></li>
<li><strong>LH/FSH-PRL-Î²-endorfin</strong></li>
<li><strong>GH-ACTH</strong></li>
<li><strong>PRL-TSH</strong></li>
</ul>
</section>

<section id="null-hÃ¼cre-adenomu" class="title-slide slide level1 center">
<h1>Null HÃ¼cre Adenomu</h1>
<p><strong>%20, giderek dÃ¼ÅÃ¼yor</strong></p>
<p><strong>Suprasellar, parasellar invazyon</strong></p>
<p><strong>Kavitasyon, kanama</strong></p>
<p><strong>Yuvarlak, poligonal, kromofob</strong></p>
<p><strong>DiffÃ¼z, papiller</strong></p>
<p><strong>Pleomorfizm, mitoz nadir</strong></p>
</section>

<section id="invaziv" class="title-slide slide level1 center">
<h1>Ä°nvaziv</h1>
<p><strong>Kemik</strong></p>
<p><strong>KavernÃ¶z sinÃ¼s</strong></p>
<p><strong>Nazofarenks</strong></p>
<p><strong>Dura</strong></p>
<ul>
<li><strong>Agresif davranÄ±Å</strong>
<ul>
<li><strong>RekÃ¼rrens</strong></li>
<li><strong>Hormon dÃ¼zeyi normale dÃ¶nmez</strong></li>
</ul></li>
<li><strong>Dura invazyonu sÄ±k</strong>
<ul>
<li><strong>Agresif deÄil</strong></li>
</ul></li>
</ul>
</section>

<section id="atipik-adenom" class="title-slide slide level1 center">
<h1>Atipik adenom</h1>
<ul>
<li><strong>Biyolojik</strong>
<ul>
<li><strong>Agresif davranÄ±Å</strong></li>
<li><strong>RekÃ¼rrens</strong></li>
</ul></li>
<li><strong>Ki-67&gt;%3</strong></li>
<li><strong>p53 pozitif</strong></li>
<li><strong>Metastaz yaparlar mÄ±?</strong></li>
</ul>
</section>

<section id="hipofiz-karsinomu" class="title-slide slide level1 center">
<h1>Hipofiz karsinomu</h1>
<ul>
<li><strong>BOS ya da sistemik yayÄ±lÄ±mla tanÄ± konur</strong></li>
<li><strong>EriÅkinlerde</strong></li>
<li><strong>Nadir</strong></li>
<li><strong>PRL, GH</strong></li>
<li><strong>ACTH olanlar Nelson zemininde</strong></li>
<li><strong>Ä°nvazyon, pleomorfizm, mitoz ve nekroz izlenir</strong>
<ul>
<li><strong>Ancak tanÄ±sal ya da prediktif deÄildir</strong></li>
</ul></li>
</ul>
</section>

<section id="cadillac-approach" class="title-slide slide level1 center">
<h1>Cadillac approach</h1>
<p><strong>Acta Neuropathol (2006) 111: 68â70</strong></p>
</section>

<section id="section-4" class="title-slide slide level1 center">
<h1></h1>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B149.png"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B150.png"></p>
</section>

<section id="hipofiz-adenomu-2" class="title-slide slide level1 center">
<h1>Hipofiz adenomu</h1>

</section>

<section id="dialar" class="title-slide slide level1 center">
<h1>dialar</h1>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B151.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B152.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B153.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B154.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B155.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B156.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B157.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B158.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B159.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B160.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B161.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B162.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B163.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B164.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B165.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B166.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B167.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B168.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B169.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B170.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B171.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B172.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B173.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B174.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B175.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B176.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B177.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B178.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B179.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B180.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B181.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B182.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B183.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B184.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B185.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B186.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B187.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B188.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B189.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B190.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B191.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B192.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B193.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B194.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B195.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B196.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B197.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B198.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B199.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1100.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1101.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1102.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1103.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1104.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1105.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1106.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1107.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1108.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1109.jpg"></p>
<p><img data-src="img%5CHipofiz-Hastal%C4%B1klar%C4%B1110.jpg"></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="hipofiz-hastaliklari_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>